Richards Timothy T.
SEC Form 4 insider trading activity
Richards Timothy T. has filed 7 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Jul 6, 2026.
On the most recent filing, Richards Timothy T. is listed as Director at ClearPoint Neuro, Inc. Inside the rolling window, Richards Timothy T. reported no open-market purchases and 1 open-market sale totaling $66K in CLPT.
Companies traded
Other insiders at CLPT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$66K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Richards Timothy T. made?
Richards Timothy T. has filed 7 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Richards Timothy T. trade?
Richards Timothy T. has filed SEC Form 4 disclosures for 1 company, including CLPT.
When was Richards Timothy T.'s most recent SEC Form 4 filing?
Richards Timothy T.'s most recent SEC Form 4 filing on Tracefour is dated Jul 6, 2026.
What is Richards Timothy T.'s total buy and sell value in the current window?
Inside the rolling retention window, Richards Timothy T. bought $0 and sold $66K based on SEC Form 4 filings.
What was Richards Timothy T.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,415 CLPT shares on 2026-06-01, worth $66K, per SEC Form 4 filings.